Financials · JEF

Jefferies Financial Group Inc. (JEF) financials

For the twelve months ended Aug 31, 2026, Jefferies Financial Group Inc. reported $12.17B of revenue and $857.62M of net income.

Revenue, TTM
$12.17B
Revenue growth, YoY
+13.5%
Net income, TTM
$857.62M
Net income growth, YoY
+26.6%
Net margin
7.0%
Free cash flow, TTM
$4.20B
Cash
$16.88B
Total debt
$18.46B
P/E
13.23
P/S
0.93
Market cap
$11.34B
Annual revenue$10.82B
FY2015FY2025
Annual net income$630.79M
FY2015FY2025
Annual free cash flow-$1.70B
FY2020FY2025

JEF revenue and earnings growth

JEF revenueQ3 2026$3.23B

Quarter YoY
+11.1%
QoQ
+3.6%
FY YoY
+2.9%
5Y CAGR
+9.5%
10Y CAGR
-0.8%

JEF revenue was $3.23B in fiscal Q3 2026 (ended Aug 31, 2026), up 11.1% from a year earlier and up 3.6% from the prior quarter. For the full fiscal 2025 it was $10.82B, up 2.9% from fiscal 2024. Compound annual growth was +9.5% over 5 years and -0.8% over 10 years. It rose in 5 of the last 6 fiscal years.

JEF net incomeQ3 2026$288.25M

Quarter YoY
+18.9%
QoQ
+15.3%
FY YoY
-5.7%
5Y CAGR
-3.8%
10Y CAGR
+8.5%

JEF net income was $288.25M in fiscal Q3 2026 (ended Aug 31, 2026), up 18.9% from a year earlier and up 15.3% from the prior quarter. For the full fiscal 2025 it was $630.79M, down 5.7% from fiscal 2024. Compound annual growth was -3.8% over 5 years and +8.5% over 10 years. It rose in 2 of the last 6 fiscal years.

JEF EPSQ1 2026$0.70

Quarter YoY
+22.8%
QoQ
-17.6%
FY YoY
-5.4%
5Y CAGR
+1.3%

JEF diluted EPS was $0.70 in fiscal Q1 2026 (ended Feb 28, 2026), up 22.8% from a year earlier and down 17.6% from the prior quarter. For the full fiscal 2025 it was $2.83, down 5.4% from fiscal 2024. Compound annual growth was +1.3% over 5 years.

JEF free cash flowQ3 2026$2.54B

Quarter YoY
20x
QoQ
+63.9%

JEF free cash flow was $2.54B in fiscal Q3 2026 (ended Aug 31, 2026), up about 20-fold from a year earlier and up 63.9% from the prior quarter. For the full fiscal 2025 it was -$1.70B, compared with -$391.05M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
Nov 30, 2025
Nov 30, 2024
Nov 30, 2023
Nov 30, 2022
Nov 30, 2021
Nov 30, 2020
Nov 30, 2019
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Revenue$10.82B$10.52B$7.44B$7.15B$8.95B$6.88B$5.36B$5.05B$3.85B$11.68B
Cost of revenue$190.93M$206.28M$29.43M$440.84M$470.87M$338.59M$319.64M$280.95M$337.04M$7.68B
Gross profit$10.63B$10.31B$7.41B$6.71B$8.47B$6.54B$5.04B$4.77B$3.51B$4.01B
Selling, general and admin----$0$0$1.01B$778.05M$797.13M$757.79M
Interest expense--$2.74B$1.17B$931.64M$1.03B$87.18M$101.20M$95.76M$115.80M
Pre-tax income$870.99M$1.01B$354.27M$1.06B$2.25B$1.07B$478.61M$606.50M-$12.59M$356.54M
Income tax$184.57M$293.19M$91.88M$273.85M$576.73M$298.67M-$483.95M$642.29M$25.77M$109.95M
Net income$630.79M$669.27M$260.94M$774.15M$1.66B$764.81M$959.59M$167.35M$125.94M$279.59M
EPS, basic$2.93$3.08$1.12$3.13$6.29$2.68$3.07$0.45$0.34$0.74
EPS, diluted$2.83$2.99$1.10$3.06$6.13$2.65$3.03$0.45$0.34$0.74
Diluted shares222.7M223.7M236.6M255.6M271.5M290.5M317.0M370.7M371.5M372.4M

Balance sheet

Balance sheet
Line item
Nov 30, 2025
Nov 30, 2024
Nov 30, 2023
Nov 30, 2022
Nov 30, 2021
Nov 30, 2020
Nov 30, 2019
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Cash and equivalents$14.04B$13.17B$9.83B$10.71B$11.83B$9.66B$8.48B$5.77B$4.60B$4.46B
Inventory--------$309.94M$288.07M
Goodwill$1.84B$1.83B$1.85B$1.74B$1.75B$1.75B$1.74B$1.72B$1.72B$1.74B
Total assets$76.01B$64.36B$57.91B$51.06B$56.11B$53.12B$49.46B$47.17B$45.07B$46.33B
Short-term debt$1.77B$443.16M$989.72M$528.39M$221.86M$764.72M$548.49M$436.21M$525.84M$310.66M
Total debt$15.90B$13.53B$9.70B$8.77B$9.13B$8.35B$8.34B$7.89B$7.38B$7.40B
Total liabilities$65.37B$54.13B$48.10B$40.63B$45.38B$43.53B$39.71B$36.48B$34.31B$35.55B
Shareholders' equity$10.57B$10.16B$9.80B$10.30B$10.58B$9.44B$9.60B$10.14B$10.30B$10.47B

Cash flow

Cash flow
Line item
Nov 30, 2025
Nov 30, 2024
Nov 30, 2023
Nov 30, 2022
Nov 30, 2021
Nov 30, 2020
Nov 30, 2019
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Operating cash flow-$1.50B-$140.47M-$1.93B$1.80B$1.58B$2.06B-$827.84M$788.29M$572.41M-$761.75M
Capital expenditures$207.47M$250.58M$1.16M$224.30M$165.60M$176.96M----
Free cash flow-$1.70B-$391.05M-$1.93B$1.58B$1.42B$1.88B----
Investing cash flow-$298.81M$210.31M-$12.20M-$60.54M-$409.87M-$165.68M$1.71B-$54.63M-$636.22M$781.16M
Financing cash flow$3.59B$3.52B$1.06B-$2.84B$994.29M-$723.52M$1.59B$434.80M$230.91M-$651.98M
Dividends paid$374.13M$302.96M$278.60M$280.10M$222.80M$160.94M$149.65M$117.41M$91.30M$92.55M
Share repurchases$58.52M$44.31M$169.40M$859.59M$269.40M$816.87M$509.91M$100.48M$95.02M$125.75M
Stock-based compensation$88.23M$63.12M$45.36M$43.92M$78.16M$40.04M$49.85M$48.38M$33.60M$74.09M
Depreciation and amortization$192.28M$190.33M$112.20M$172.90M$157.42M$158.44M$152.87M$110.39M$117.11M$224.13M

Key ratios

Key ratios
Line item
Nov 30, 2025
Nov 30, 2024
Nov 30, 2023
Nov 30, 2022
Nov 30, 2021
Nov 30, 2020
Nov 30, 2019
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Revenue growth, YoY2.9%41.3%4.1%-20.1%30.0%28.4%-31.2%-67.1%-5.3%
Net income growth, YoY-5.7%156.5%-66.3%-53.3%116.7%-20.3%-32.9%-55.0%36.8%
EPS growth, YoY-5.4%171.8%-64.1%-50.1%131.3%-12.5%-32.4%-54.1%37.0%
Gross margin98.2%98.0%99.6%93.8%94.7%95.1%94.0%94.4%91.2%34.3%
Net margin5.8%6.4%3.5%10.8%18.5%11.1%17.9%3.3%3.3%2.4%
Free cash flow margin-15.7%-3.7%-26.0%22.1%15.8%27.3%----
Return on equity6.0%6.6%2.7%7.5%15.7%8.1%10.0%1.7%1.2%2.7%
Return on assets0.8%1.0%0.5%1.5%3.0%1.4%1.9%0.4%0.3%0.6%
Debt to equity1.501.330.990.850.860.880.870.780.720.71

Source: XBRL data Jefferies Financial Group Inc. files with the SEC, latest filing dated Oct 9, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

JEF peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
JEF$12.17B+13.5%$857.62M7.0%$11.34B
MS$80.16B+16.2%$20.45B25.5%$292.45B
GS$69.70B+18.7%$22.17B31.8%$261.38B
BLK$28.54B+24.7%$6.91B24.2%$187.58B
SCHW$27.06B+18.1%$10.64B39.3%$160.36B
CME$6.97B+9.0%$4.43B63.5%$109.00B
ICE$14.05B+12.1%$4.16B29.6%$97.26B
HOOD$5.08B+20.9%$1.98B39.0%$75.03B
NDAQ$9.15B+11.5%$2.08B22.8%$60.21B

JEF FAQ

8 questions
  • What is JEF revenue?
    Jefferies Financial Group Inc. (JEF) reported $12.17B of revenue for the twelve months ended Aug 31, 2026. That is up 13.5% from the year before. Revenue for fiscal 2025 was $10.82B.
  • Is JEF profitable?
    Yes. Jefferies Financial Group Inc. earned $857.62M in net income for the twelve months ended Aug 31, 2026, a net margin of 7.0%.
  • How much cash and debt does JEF have?
    Jefferies Financial Group Inc. reported $16.88B in cash and cash equivalents and $18.46B of debt on its most recent balance sheet in SEC filings.
  • How fast is JEF revenue growing?
    Jefferies Financial Group Inc.'s revenue changed +2.9% in fiscal 2025, to $10.82B. Its compound annual growth rate was +9.5% over 5 years and -0.8% over 10 years.
  • What is JEF gross margin?
    Jefferies Financial Group Inc.'s gross profit was $12.01B on $12.17B of revenue for the twelve months ended Aug 31, 2026, a gross margin of 98.7%.
  • What is JEF free cash flow?
    Jefferies Financial Group Inc. generated $4.20B of free cash flow for the twelve months ended Aug 31, 2026, which is operating cash flow of $4.42B less capital expenditures.
  • When did JEF last report financial results?
    The latest statements here come from Jefferies Financial Group Inc.'s 10-Q filed on Oct 9, 2026, covering the period ended Aug 31, 2026.
  • Where does this JEF financial data come from?
    Quantisnow builds these statements from the structured XBRL data Jefferies Financial Group Inc. files with the SEC. It is provided for information only and is not investment advice.